carisoprodol

Generic: carisoprodol

Labeler: mylan pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name carisoprodol
Generic Name carisoprodol
Labeler mylan pharmaceuticals inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

carisoprodol 250 mg/1

Manufacturer
Mylan Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 51525-5901
Product ID 51525-5901_8c92753a-4b60-4ecf-b411-d66665ae493e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA011792
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2016-10-01

Pharmacologic Class

Established (EPC)
muscle relaxant [epc]
Physiologic Effect
centrally-mediated muscle relaxation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 515255901
Hyphenated Format 51525-5901

Supplemental Identifiers

RxCUI
730794
UNII
21925K482H
NUI
N0000175730 N0000175737

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name carisoprodol (source: ndc)
Generic Name carisoprodol (source: ndc)
Application Number NDA011792 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (51525-5901-1)
source: ndc

Packages (1)

51525-5901-1 100 TABLET in 1 BOTTLE (51525-5901-1)

Ingredients (1)

carisoprodol (250 mg/1)

Linked Drug Pages (1)

Carisoprodol ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8c92753a-4b60-4ecf-b411-d66665ae493e", "openfda": {"nui": ["N0000175730", "N0000175737"], "unii": ["21925K482H"], "rxcui": ["730794"], "spl_set_id": ["7c9184c0-7a2e-11df-8c8d-0002a5d5c51b"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (51525-5901-1)", "package_ndc": "51525-5901-1", "marketing_start_date": "20161001"}], "brand_name": "Carisoprodol", "product_id": "51525-5901_8c92753a-4b60-4ecf-b411-d66665ae493e", "dosage_form": "TABLET", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "51525-5901", "dea_schedule": "CIV", "generic_name": "carisoprodol", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carisoprodol", "active_ingredients": [{"name": "CARISOPRODOL", "strength": "250 mg/1"}], "application_number": "NDA011792", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20161001", "listing_expiration_date": "20261231"}